Business and Innovation

Business & Profession Business and Innovation

The Final Frontier

04/29/2019 | Phoebe Harkin

Jim Mazzo on joining the Board of Directors at Avellino Labs

Subspecialties Retina

A New Step Forward

04/03/2019 | Sponsored by Alimera

Addressing the challenge of diabetic macular edema with ILUVIEN®: views from the Expert User Group Meeting in Rome, November 17, 2018

Subspecialties Cornea / Ocular Surface

Smaller Drops, Bigger Impact

03/27/2019 | Sponsored by Novaliq

We’ll never live in an ideal world – but Novaliq’s water-free EyeSol® technology just might make the ideal eye-drop

Business & Profession Business and Innovation

Business in Brief

03/20/2019 | Phoebe Harkin

The latest corporate news – on earth and in outer space.

Subspecialties Glaucoma

The Import of Space and Time

03/08/2019 | Sponsored by Haag-Streit Diagnostics

During glaucoma progression, subtle changes can be masked by background fluctuations – and, therefore, entirely missed by standard monitoring methods.

Subspecialties Business and Innovation

Genetic Versus Economic

03/05/2019 | Aleksandra Jones

Our newfound ability to harness the power of gene therapy is facing an age-old challenge: financial constraints

Subspecialties Imaging & Diagnostics

Always Illuminating

02/20/2019 | Sponsored by Leica Microsystems

Ultra-reliable red reflex, increased depth of field, and highly accessible settings make the Proveo 8 stand out from the crowd

Subspecialties Cataract

From Intelligence Comes Perfection

02/20/2019 | Sponsored by Haag-Streit Diagnostics

The AI-driven Hill-RBF 2.0 pushes the boundaries of accuracy in IOL predictions

Business & Profession Business and Innovation

In Safe – and Simple – Hands

02/19/2019 | Sponsored by Oertli

The Faros™ platform from Oertli delivers the surgery outcomes you truly desire with easyPhaco® technology and the unique SPEEPMode™

Subspecialties Refractive

How to Prevent Patients from Missing Out on Laser Vision Correction

02/02/2019 | Allon Barsam

What needs to be done to improve laser vision correction rates, and get potential refractive surgery candidates to commit to the procedure?